PLEASANTON, Calif.,
Jan. 28, 2015 /PRNewswire/ --
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based
mechanical circulatory support therapies to save, support and
restore failing hearts, today announced that it will report its
operating results for the fourth quarter of fiscal year 2014 on
Tuesday, February 10.
The company will hold a conference call to discuss its financial
results and operating activities, open to all interested parties,
at 1:30 p.m., Pacific Standard Time
(4:30 p.m., Eastern Standard Time),
Tuesday, February 10, hosted by
D. Keith Grossman, President and
Chief Executive Officer, and Taylor C.
Harris, Vice President and Chief Financial Officer.
The teleconference can be accessed by calling (913) 312-0648,
passcode 9653185. Please dial in 10-15 minutes prior to the
beginning of the call. The webcast will be available on the
Internet at http://edge.media-server.com/m/p/45o4cryf/lan/en, or
http://www.thoratec.com.
A replay of the conference call will be available through
Tuesday, February 17, via
http://www.thoratec.com, or by telephone at (719) 457-0820,
passcode 9653185.
Thoratec is a world leader in therapies to address
advanced-stage heart failure. The company's products include
the HeartMate II® and HeartMate III™ LVAS (Left Ventricular Assist
Systems) and Thoratec® VAD (Ventricular Assist Device) with more
than 20,000 devices implanted in patients suffering from heart
failure. Thoratec also manufactures and distributes the
CentriMag®, PediMag®/PediVAS®, and HeartMate PHP™ product
lines. HeartMate III is an investigational device and is
limited by US law to investigational use. HeartMate PHP is
currently in development and not approved for sale. Thoratec is
headquartered in Pleasanton,
California. For more information, visit the company's website
at http://www.thoratec.com.
Thoratec, the Thoratec logo, HeartMate, and HeartMate II are
registered trademarks of Thoratec Corporation and HeartMate III,
HeartMate PHP, and IVAD are trademarks of Thoratec
Corporation. CentriMag and PediMag are registered trademarks
of Thoratec LLC, and PediVAS is a registered trademark of Thoratec
Switzerland GmbH.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/thoratec-schedules-fourth-quarter-conference-call-webcast-300027426.html
SOURCE Thoratec Corporation